nodes	percent_of_prediction	percent_of_DWPC	metapath
Torasemide—CYP2C8—Mometasone—systemic scleroderma	0.284	0.473	CbGbCtD
Torasemide—CYP2C9—Leflunomide—systemic scleroderma	0.127	0.213	CbGbCtD
Torasemide—CYP2C8—Mycophenolate mofetil—systemic scleroderma	0.113	0.188	CbGbCtD
Torasemide—CYP2C19—Prednisone—systemic scleroderma	0.0757	0.126	CbGbCtD
Torasemide—CYP2C9—cardial valve—systemic scleroderma	0.0216	0.58	CbGeAlD
Torasemide—PTGS1—artery—systemic scleroderma	0.00296	0.0795	CbGeAlD
Torasemide—PTGS1—endothelium—systemic scleroderma	0.0025	0.0672	CbGeAlD
Torasemide—PTGS1—blood vessel—systemic scleroderma	0.0023	0.0619	CbGeAlD
Torasemide—Thrombocytopenia—Pentoxifylline—systemic scleroderma	0.0014	0.00386	CcSEcCtD
Torasemide—Stevens-Johnson syndrome—Leflunomide—systemic scleroderma	0.00139	0.00382	CcSEcCtD
Torasemide—Angioedema—Mometasone—systemic scleroderma	0.00138	0.00381	CcSEcCtD
Torasemide—Erectile dysfunction—Mycophenolic acid—systemic scleroderma	0.00138	0.0038	CcSEcCtD
Torasemide—Hyponatraemia—Mycophenolate mofetil—systemic scleroderma	0.00137	0.00378	CcSEcCtD
Torasemide—Gastrointestinal haemorrhage—Mycophenolate mofetil—systemic scleroderma	0.00137	0.00377	CcSEcCtD
Torasemide—Hyperglycaemia—Mycophenolic acid—systemic scleroderma	0.00135	0.00372	CcSEcCtD
Torasemide—Haemoglobin—Azathioprine—systemic scleroderma	0.00134	0.00369	CcSEcCtD
Torasemide—Hypotension—Pentoxifylline—systemic scleroderma	0.00134	0.00368	CcSEcCtD
Torasemide—Haemorrhage—Azathioprine—systemic scleroderma	0.00133	0.00367	CcSEcCtD
Torasemide—Pancreatitis—Lisinopril—systemic scleroderma	0.00132	0.00364	CcSEcCtD
Torasemide—Cough—Mometasone—systemic scleroderma	0.00132	0.00363	CcSEcCtD
Torasemide—Tension—Captopril—systemic scleroderma	0.0013	0.00359	CcSEcCtD
Torasemide—Musculoskeletal discomfort—Pentoxifylline—systemic scleroderma	0.0013	0.00359	CcSEcCtD
Torasemide—Insomnia—Pentoxifylline—systemic scleroderma	0.00129	0.00356	CcSEcCtD
Torasemide—Nervousness—Captopril—systemic scleroderma	0.00129	0.00355	CcSEcCtD
Torasemide—Chest pain—Mometasone—systemic scleroderma	0.00129	0.00355	CcSEcCtD
Torasemide—Myalgia—Mometasone—systemic scleroderma	0.00129	0.00355	CcSEcCtD
Torasemide—Arthralgia—Mometasone—systemic scleroderma	0.00129	0.00355	CcSEcCtD
Torasemide—Dehydration—Mycophenolate mofetil—systemic scleroderma	0.00127	0.0035	CcSEcCtD
Torasemide—Haemoglobin—Leflunomide—systemic scleroderma	0.00126	0.00348	CcSEcCtD
Torasemide—Rhinitis—Leflunomide—systemic scleroderma	0.00126	0.00347	CcSEcCtD
Torasemide—Dyspepsia—Pentoxifylline—systemic scleroderma	0.00126	0.00347	CcSEcCtD
Torasemide—Erythema multiforme—Azathioprine—systemic scleroderma	0.00126	0.00347	CcSEcCtD
Torasemide—Haemorrhage—Leflunomide—systemic scleroderma	0.00126	0.00346	CcSEcCtD
Torasemide—Hypokalaemia—Mycophenolate mofetil—systemic scleroderma	0.00125	0.00343	CcSEcCtD
Torasemide—Erectile dysfunction—Lisinopril—systemic scleroderma	0.00124	0.00342	CcSEcCtD
Torasemide—Constipation—Pentoxifylline—systemic scleroderma	0.00122	0.00337	CcSEcCtD
Torasemide—Hyperglycaemia—Lisinopril—systemic scleroderma	0.00122	0.00335	CcSEcCtD
Torasemide—Angioedema—Captopril—systemic scleroderma	0.00121	0.00334	CcSEcCtD
Torasemide—Haemoglobin—Mycophenolic acid—systemic scleroderma	0.00121	0.00332	CcSEcCtD
Torasemide—CYP2C19—digestive system—systemic scleroderma	0.0012	0.0324	CbGeAlD
Torasemide—Rhinitis—Mycophenolic acid—systemic scleroderma	0.0012	0.00331	CcSEcCtD
Torasemide—Haemorrhage—Mycophenolic acid—systemic scleroderma	0.0012	0.0033	CcSEcCtD
Torasemide—Stevens-Johnson syndrome—Lisinopril—systemic scleroderma	0.00119	0.00329	CcSEcCtD
Torasemide—Syncope—Captopril—systemic scleroderma	0.00119	0.00328	CcSEcCtD
Torasemide—Erythema multiforme—Leflunomide—systemic scleroderma	0.00119	0.00327	CcSEcCtD
Torasemide—PTGS1—connective tissue—systemic scleroderma	0.00118	0.0318	CbGeAlD
Torasemide—Loss of consciousness—Captopril—systemic scleroderma	0.00117	0.00321	CcSEcCtD
Torasemide—Pancreatitis—Mycophenolate mofetil—systemic scleroderma	0.00116	0.00319	CcSEcCtD
Torasemide—Cough—Captopril—systemic scleroderma	0.00116	0.00319	CcSEcCtD
Torasemide—Hyperuricaemia—Methotrexate—systemic scleroderma	0.00115	0.00317	CcSEcCtD
Torasemide—Chest pain—Captopril—systemic scleroderma	0.00113	0.00311	CcSEcCtD
Torasemide—Myalgia—Captopril—systemic scleroderma	0.00113	0.00311	CcSEcCtD
Torasemide—Arthralgia—Captopril—systemic scleroderma	0.00113	0.00311	CcSEcCtD
Torasemide—Musculoskeletal discomfort—Mometasone—systemic scleroderma	0.00113	0.0031	CcSEcCtD
Torasemide—Erectile dysfunction—Mycophenolate mofetil—systemic scleroderma	0.00109	0.003	CcSEcCtD
Torasemide—Blood uric acid increased—Methotrexate—systemic scleroderma	0.00109	0.003	CcSEcCtD
Torasemide—Dyspepsia—Mometasone—systemic scleroderma	0.00109	0.00299	CcSEcCtD
Torasemide—Rhinitis—Lisinopril—systemic scleroderma	0.00108	0.00298	CcSEcCtD
Torasemide—PTGS1—smooth muscle tissue—systemic scleroderma	0.00108	0.029	CbGeAlD
Torasemide—Hyperglycaemia—Mycophenolate mofetil—systemic scleroderma	0.00107	0.00294	CcSEcCtD
Torasemide—Shock—Captopril—systemic scleroderma	0.00107	0.00294	CcSEcCtD
Torasemide—PTGS1—skin of body—systemic scleroderma	0.00107	0.0287	CbGeAlD
Torasemide—Thrombocytopenia—Captopril—systemic scleroderma	0.00106	0.00292	CcSEcCtD
Torasemide—Pain—Mometasone—systemic scleroderma	0.00106	0.00291	CcSEcCtD
Torasemide—Leukopenia—Azathioprine—systemic scleroderma	0.00104	0.00286	CcSEcCtD
Torasemide—Asthenia—Pentoxifylline—systemic scleroderma	0.00103	0.00283	CcSEcCtD
Torasemide—Tension—Mycophenolic acid—systemic scleroderma	0.00103	0.00282	CcSEcCtD
Torasemide—Erythema multiforme—Lisinopril—systemic scleroderma	0.00102	0.00281	CcSEcCtD
Torasemide—Nervousness—Mycophenolic acid—systemic scleroderma	0.00101	0.00279	CcSEcCtD
Torasemide—Hypotension—Captopril—systemic scleroderma	0.00101	0.00279	CcSEcCtD
Torasemide—Angioedema—Leflunomide—systemic scleroderma	0.001	0.00275	CcSEcCtD
Torasemide—Musculoskeletal discomfort—Captopril—systemic scleroderma	0.000988	0.00272	CcSEcCtD
Torasemide—Arthralgia—Azathioprine—systemic scleroderma	0.000987	0.00272	CcSEcCtD
Torasemide—Myalgia—Azathioprine—systemic scleroderma	0.000987	0.00272	CcSEcCtD
Torasemide—Insomnia—Captopril—systemic scleroderma	0.000981	0.0027	CcSEcCtD
Torasemide—Leukopenia—Leflunomide—systemic scleroderma	0.00098	0.0027	CcSEcCtD
Torasemide—Diarrhoea—Pentoxifylline—systemic scleroderma	0.000979	0.0027	CcSEcCtD
Torasemide—Cough—Leflunomide—systemic scleroderma	0.000956	0.00263	CcSEcCtD
Torasemide—Dyspepsia—Captopril—systemic scleroderma	0.000955	0.00263	CcSEcCtD
Torasemide—Haemoglobin—Mycophenolate mofetil—systemic scleroderma	0.000952	0.00262	CcSEcCtD
Torasemide—Rhinitis—Mycophenolate mofetil—systemic scleroderma	0.00095	0.00261	CcSEcCtD
Torasemide—Haemorrhage—Mycophenolate mofetil—systemic scleroderma	0.000947	0.00261	CcSEcCtD
Torasemide—Dizziness—Pentoxifylline—systemic scleroderma	0.000946	0.0026	CcSEcCtD
Torasemide—Syncope—Mycophenolic acid—systemic scleroderma	0.000937	0.00258	CcSEcCtD
Torasemide—Leukopenia—Mycophenolic acid—systemic scleroderma	0.000935	0.00257	CcSEcCtD
Torasemide—CYP2C9—digestive system—systemic scleroderma	0.000934	0.0251	CbGeAlD
Torasemide—Chest pain—Leflunomide—systemic scleroderma	0.000933	0.00257	CcSEcCtD
Torasemide—Myalgia—Leflunomide—systemic scleroderma	0.000933	0.00257	CcSEcCtD
Torasemide—Arthralgia—Leflunomide—systemic scleroderma	0.000933	0.00257	CcSEcCtD
Torasemide—Gastrointestinal haemorrhage—Prednisone—systemic scleroderma	0.000928	0.00255	CcSEcCtD
Torasemide—Constipation—Captopril—systemic scleroderma	0.000928	0.00255	CcSEcCtD
Torasemide—Thrombocytopenia—Azathioprine—systemic scleroderma	0.000927	0.00255	CcSEcCtD
Torasemide—Tension—Lisinopril—systemic scleroderma	0.000924	0.00254	CcSEcCtD
Torasemide—Loss of consciousness—Mycophenolic acid—systemic scleroderma	0.000918	0.00253	CcSEcCtD
Torasemide—Nervousness—Lisinopril—systemic scleroderma	0.000914	0.00252	CcSEcCtD
Torasemide—Cough—Mycophenolic acid—systemic scleroderma	0.000912	0.00251	CcSEcCtD
Torasemide—Vomiting—Pentoxifylline—systemic scleroderma	0.00091	0.0025	CcSEcCtD
Torasemide—Rash—Pentoxifylline—systemic scleroderma	0.000902	0.00248	CcSEcCtD
Torasemide—Dermatitis—Pentoxifylline—systemic scleroderma	0.000902	0.00248	CcSEcCtD
Torasemide—Headache—Pentoxifylline—systemic scleroderma	0.000897	0.00247	CcSEcCtD
Torasemide—Chest pain—Mycophenolic acid—systemic scleroderma	0.00089	0.00245	CcSEcCtD
Torasemide—Myalgia—Mycophenolic acid—systemic scleroderma	0.00089	0.00245	CcSEcCtD
Torasemide—Arthralgia—Mycophenolic acid—systemic scleroderma	0.00089	0.00245	CcSEcCtD
Torasemide—Asthenia—Mometasone—systemic scleroderma	0.000886	0.00244	CcSEcCtD
Torasemide—Hypotension—Azathioprine—systemic scleroderma	0.000885	0.00243	CcSEcCtD
Torasemide—Thrombocytopenia—Leflunomide—systemic scleroderma	0.000875	0.00241	CcSEcCtD
Torasemide—Musculoskeletal discomfort—Azathioprine—systemic scleroderma	0.000862	0.00237	CcSEcCtD
Torasemide—Angioedema—Lisinopril—systemic scleroderma	0.00086	0.00237	CcSEcCtD
Torasemide—PTGS1—digestive system—systemic scleroderma	0.000853	0.0229	CbGeAlD
Torasemide—Oedema—Mycophenolic acid—systemic scleroderma	0.000853	0.00235	CcSEcCtD
Torasemide—Nausea—Pentoxifylline—systemic scleroderma	0.00085	0.00234	CcSEcCtD
Torasemide—Diarrhoea—Mometasone—systemic scleroderma	0.000845	0.00233	CcSEcCtD
Torasemide—Hypokalaemia—Prednisone—systemic scleroderma	0.000845	0.00232	CcSEcCtD
Torasemide—Syncope—Lisinopril—systemic scleroderma	0.000844	0.00232	CcSEcCtD
Torasemide—Leukopenia—Lisinopril—systemic scleroderma	0.000842	0.00232	CcSEcCtD
Torasemide—Shock—Mycophenolic acid—systemic scleroderma	0.000839	0.00231	CcSEcCtD
Torasemide—Hypotension—Leflunomide—systemic scleroderma	0.000835	0.0023	CcSEcCtD
Torasemide—Thrombocytopenia—Mycophenolic acid—systemic scleroderma	0.000835	0.0023	CcSEcCtD
Torasemide—Loss of consciousness—Lisinopril—systemic scleroderma	0.000827	0.00228	CcSEcCtD
Torasemide—Cough—Lisinopril—systemic scleroderma	0.000821	0.00226	CcSEcCtD
Torasemide—Musculoskeletal discomfort—Leflunomide—systemic scleroderma	0.000814	0.00224	CcSEcCtD
Torasemide—PTGS1—tendon—systemic scleroderma	0.000812	0.0218	CbGeAlD
Torasemide—Tension—Mycophenolate mofetil—systemic scleroderma	0.000809	0.00223	CcSEcCtD
Torasemide—Insomnia—Leflunomide—systemic scleroderma	0.000809	0.00223	CcSEcCtD
Torasemide—Myalgia—Lisinopril—systemic scleroderma	0.000801	0.00221	CcSEcCtD
Torasemide—Arthralgia—Lisinopril—systemic scleroderma	0.000801	0.00221	CcSEcCtD
Torasemide—Chest pain—Lisinopril—systemic scleroderma	0.000801	0.00221	CcSEcCtD
Torasemide—Nervousness—Mycophenolate mofetil—systemic scleroderma	0.000801	0.0022	CcSEcCtD
Torasemide—Hypotension—Mycophenolic acid—systemic scleroderma	0.000797	0.00219	CcSEcCtD
Torasemide—Dyspepsia—Leflunomide—systemic scleroderma	0.000787	0.00217	CcSEcCtD
Torasemide—Pancreatitis—Prednisone—systemic scleroderma	0.000787	0.00216	CcSEcCtD
Torasemide—Vomiting—Mometasone—systemic scleroderma	0.000785	0.00216	CcSEcCtD
Torasemide—Rash—Mometasone—systemic scleroderma	0.000779	0.00214	CcSEcCtD
Torasemide—Asthenia—Captopril—systemic scleroderma	0.000778	0.00214	CcSEcCtD
Torasemide—Dermatitis—Mometasone—systemic scleroderma	0.000778	0.00214	CcSEcCtD
Torasemide—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.000777	0.00214	CcSEcCtD
Torasemide—Headache—Mometasone—systemic scleroderma	0.000774	0.00213	CcSEcCtD
Torasemide—Insomnia—Mycophenolic acid—systemic scleroderma	0.000771	0.00212	CcSEcCtD
Torasemide—Oedema—Lisinopril—systemic scleroderma	0.000768	0.00211	CcSEcCtD
Torasemide—Constipation—Leflunomide—systemic scleroderma	0.000764	0.0021	CcSEcCtD
Torasemide—Pain—Leflunomide—systemic scleroderma	0.000764	0.0021	CcSEcCtD
Torasemide—Shock—Lisinopril—systemic scleroderma	0.000756	0.00208	CcSEcCtD
Torasemide—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.000754	0.00207	CcSEcCtD
Torasemide—Thrombocytopenia—Lisinopril—systemic scleroderma	0.000752	0.00207	CcSEcCtD
Torasemide—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.000751	0.00207	CcSEcCtD
Torasemide—Diarrhoea—Captopril—systemic scleroderma	0.000742	0.00204	CcSEcCtD
Torasemide—Syncope—Mycophenolate mofetil—systemic scleroderma	0.00074	0.00204	CcSEcCtD
Torasemide—Erectile dysfunction—Prednisone—systemic scleroderma	0.000739	0.00203	CcSEcCtD
Torasemide—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.000738	0.00203	CcSEcCtD
Torasemide—Nausea—Mometasone—systemic scleroderma	0.000734	0.00202	CcSEcCtD
Torasemide—Pain—Mycophenolic acid—systemic scleroderma	0.000729	0.00201	CcSEcCtD
Torasemide—Constipation—Mycophenolic acid—systemic scleroderma	0.000729	0.00201	CcSEcCtD
Torasemide—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.000725	0.00199	CcSEcCtD
Torasemide—Hyperglycaemia—Prednisone—systemic scleroderma	0.000724	0.00199	CcSEcCtD
Torasemide—Cough—Mycophenolate mofetil—systemic scleroderma	0.00072	0.00198	CcSEcCtD
Torasemide—Hypotension—Lisinopril—systemic scleroderma	0.000718	0.00198	CcSEcCtD
Torasemide—Dizziness—Captopril—systemic scleroderma	0.000717	0.00197	CcSEcCtD
Torasemide—PTGS1—lung—systemic scleroderma	0.000712	0.0192	CbGeAlD
Torasemide—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000702	0.00193	CcSEcCtD
Torasemide—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000702	0.00193	CcSEcCtD
Torasemide—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000702	0.00193	CcSEcCtD
Torasemide—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.0007	0.00193	CcSEcCtD
Torasemide—Toxic epidermal necrolysis—Methotrexate—systemic scleroderma	0.000699	0.00192	CcSEcCtD
Torasemide—Insomnia—Lisinopril—systemic scleroderma	0.000695	0.00191	CcSEcCtD
Torasemide—Vomiting—Captopril—systemic scleroderma	0.00069	0.0019	CcSEcCtD
Torasemide—Rash—Captopril—systemic scleroderma	0.000684	0.00188	CcSEcCtD
Torasemide—Dermatitis—Captopril—systemic scleroderma	0.000683	0.00188	CcSEcCtD
Torasemide—Headache—Captopril—systemic scleroderma	0.00068	0.00187	CcSEcCtD
Torasemide—Dyspepsia—Lisinopril—systemic scleroderma	0.000676	0.00186	CcSEcCtD
Torasemide—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000673	0.00185	CcSEcCtD
Torasemide—Shock—Mycophenolate mofetil—systemic scleroderma	0.000662	0.00182	CcSEcCtD
Torasemide—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000659	0.00181	CcSEcCtD
Torasemide—Pancreatitis—Methotrexate—systemic scleroderma	0.000657	0.00181	CcSEcCtD
Torasemide—Constipation—Lisinopril—systemic scleroderma	0.000657	0.00181	CcSEcCtD
Torasemide—Pain—Lisinopril—systemic scleroderma	0.000657	0.00181	CcSEcCtD
Torasemide—Diarrhoea—Azathioprine—systemic scleroderma	0.000648	0.00178	CcSEcCtD
Torasemide—Haemoglobin—Prednisone—systemic scleroderma	0.000645	0.00178	CcSEcCtD
Torasemide—Nausea—Captopril—systemic scleroderma	0.000644	0.00177	CcSEcCtD
Torasemide—Haemorrhage—Prednisone—systemic scleroderma	0.000642	0.00177	CcSEcCtD
Torasemide—Asthenia—Leflunomide—systemic scleroderma	0.000641	0.00177	CcSEcCtD
Torasemide—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000629	0.00173	CcSEcCtD
Torasemide—Dizziness—Azathioprine—systemic scleroderma	0.000626	0.00172	CcSEcCtD
Torasemide—Erectile dysfunction—Methotrexate—systemic scleroderma	0.000617	0.0017	CcSEcCtD
Torasemide—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000613	0.00169	CcSEcCtD
Torasemide—Asthenia—Mycophenolic acid—systemic scleroderma	0.000612	0.00168	CcSEcCtD
Torasemide—Diarrhoea—Leflunomide—systemic scleroderma	0.000612	0.00168	CcSEcCtD
Torasemide—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000609	0.00168	CcSEcCtD
Torasemide—Vomiting—Azathioprine—systemic scleroderma	0.000602	0.00166	CcSEcCtD
Torasemide—Rash—Azathioprine—systemic scleroderma	0.000597	0.00164	CcSEcCtD
Torasemide—Dermatitis—Azathioprine—systemic scleroderma	0.000596	0.00164	CcSEcCtD
Torasemide—Headache—Azathioprine—systemic scleroderma	0.000593	0.00163	CcSEcCtD
Torasemide—Stevens-Johnson syndrome—Methotrexate—systemic scleroderma	0.000593	0.00163	CcSEcCtD
Torasemide—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000592	0.00163	CcSEcCtD
Torasemide—Dizziness—Leflunomide—systemic scleroderma	0.000591	0.00163	CcSEcCtD
Torasemide—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000584	0.00161	CcSEcCtD
Torasemide—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000576	0.00158	CcSEcCtD
Torasemide—Pain—Mycophenolate mofetil—systemic scleroderma	0.000576	0.00158	CcSEcCtD
Torasemide—Vomiting—Leflunomide—systemic scleroderma	0.000568	0.00156	CcSEcCtD
Torasemide—Dizziness—Mycophenolic acid—systemic scleroderma	0.000564	0.00155	CcSEcCtD
Torasemide—Rash—Leflunomide—systemic scleroderma	0.000564	0.00155	CcSEcCtD
Torasemide—Dermatitis—Leflunomide—systemic scleroderma	0.000563	0.00155	CcSEcCtD
Torasemide—Nausea—Azathioprine—systemic scleroderma	0.000562	0.00155	CcSEcCtD
Torasemide—Headache—Leflunomide—systemic scleroderma	0.00056	0.00154	CcSEcCtD
Torasemide—Asthenia—Lisinopril—systemic scleroderma	0.000551	0.00152	CcSEcCtD
Torasemide—Vomiting—Mycophenolic acid—systemic scleroderma	0.000542	0.00149	CcSEcCtD
Torasemide—Haemoglobin—Methotrexate—systemic scleroderma	0.000539	0.00148	CcSEcCtD
Torasemide—Rash—Mycophenolic acid—systemic scleroderma	0.000538	0.00148	CcSEcCtD
Torasemide—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000537	0.00148	CcSEcCtD
Torasemide—Haemorrhage—Methotrexate—systemic scleroderma	0.000537	0.00148	CcSEcCtD
Torasemide—Headache—Mycophenolic acid—systemic scleroderma	0.000534	0.00147	CcSEcCtD
Torasemide—Nausea—Leflunomide—systemic scleroderma	0.000531	0.00146	CcSEcCtD
Torasemide—Diarrhoea—Lisinopril—systemic scleroderma	0.000526	0.00145	CcSEcCtD
Torasemide—Angioedema—Prednisone—systemic scleroderma	0.000511	0.00141	CcSEcCtD
Torasemide—Dizziness—Lisinopril—systemic scleroderma	0.000508	0.0014	CcSEcCtD
Torasemide—Erythema multiforme—Methotrexate—systemic scleroderma	0.000507	0.0014	CcSEcCtD
Torasemide—Nausea—Mycophenolic acid—systemic scleroderma	0.000507	0.00139	CcSEcCtD
Torasemide—Syncope—Prednisone—systemic scleroderma	0.000501	0.00138	CcSEcCtD
Torasemide—Loss of consciousness—Prednisone—systemic scleroderma	0.000491	0.00135	CcSEcCtD
Torasemide—Vomiting—Lisinopril—systemic scleroderma	0.000488	0.00134	CcSEcCtD
Torasemide—Rash—Lisinopril—systemic scleroderma	0.000484	0.00133	CcSEcCtD
Torasemide—Dermatitis—Lisinopril—systemic scleroderma	0.000484	0.00133	CcSEcCtD
Torasemide—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000483	0.00133	CcSEcCtD
Torasemide—Headache—Lisinopril—systemic scleroderma	0.000481	0.00132	CcSEcCtD
Torasemide—Arthralgia—Prednisone—systemic scleroderma	0.000476	0.00131	CcSEcCtD
Torasemide—Myalgia—Prednisone—systemic scleroderma	0.000476	0.00131	CcSEcCtD
Torasemide—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.00046	0.00127	CcSEcCtD
Torasemide—Nausea—Lisinopril—systemic scleroderma	0.000456	0.00126	CcSEcCtD
Torasemide—Oedema—Prednisone—systemic scleroderma	0.000456	0.00126	CcSEcCtD
Torasemide—Shock—Prednisone—systemic scleroderma	0.000449	0.00124	CcSEcCtD
Torasemide—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000445	0.00122	CcSEcCtD
Torasemide—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000428	0.00118	CcSEcCtD
Torasemide—Rash—Mycophenolate mofetil—systemic scleroderma	0.000424	0.00117	CcSEcCtD
Torasemide—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000424	0.00117	CcSEcCtD
Torasemide—Headache—Mycophenolate mofetil—systemic scleroderma	0.000422	0.00116	CcSEcCtD
Torasemide—Leukopenia—Methotrexate—systemic scleroderma	0.000418	0.00115	CcSEcCtD
Torasemide—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000416	0.00114	CcSEcCtD
Torasemide—Insomnia—Prednisone—systemic scleroderma	0.000413	0.00114	CcSEcCtD
Torasemide—Cough—Methotrexate—systemic scleroderma	0.000408	0.00112	CcSEcCtD
Torasemide—Dyspepsia—Prednisone—systemic scleroderma	0.000402	0.00111	CcSEcCtD
Torasemide—Nausea—Mycophenolate mofetil—systemic scleroderma	0.0004	0.0011	CcSEcCtD
Torasemide—Arthralgia—Methotrexate—systemic scleroderma	0.000398	0.00109	CcSEcCtD
Torasemide—Chest pain—Methotrexate—systemic scleroderma	0.000398	0.00109	CcSEcCtD
Torasemide—Myalgia—Methotrexate—systemic scleroderma	0.000398	0.00109	CcSEcCtD
Torasemide—Constipation—Prednisone—systemic scleroderma	0.00039	0.00107	CcSEcCtD
Torasemide—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000373	0.00103	CcSEcCtD
Torasemide—Hypotension—Methotrexate—systemic scleroderma	0.000356	0.000981	CcSEcCtD
Torasemide—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000347	0.000956	CcSEcCtD
Torasemide—Insomnia—Methotrexate—systemic scleroderma	0.000345	0.000949	CcSEcCtD
Torasemide—Dyspepsia—Methotrexate—systemic scleroderma	0.000336	0.000924	CcSEcCtD
Torasemide—Asthenia—Prednisone—systemic scleroderma	0.000327	0.000901	CcSEcCtD
Torasemide—Pain—Methotrexate—systemic scleroderma	0.000326	0.000897	CcSEcCtD
Torasemide—Diarrhoea—Prednisone—systemic scleroderma	0.000312	0.000859	CcSEcCtD
Torasemide—Dizziness—Prednisone—systemic scleroderma	0.000302	0.00083	CcSEcCtD
Torasemide—Vomiting—Prednisone—systemic scleroderma	0.00029	0.000798	CcSEcCtD
Torasemide—Rash—Prednisone—systemic scleroderma	0.000288	0.000792	CcSEcCtD
Torasemide—Dermatitis—Prednisone—systemic scleroderma	0.000287	0.000791	CcSEcCtD
Torasemide—Headache—Prednisone—systemic scleroderma	0.000286	0.000787	CcSEcCtD
Torasemide—Asthenia—Methotrexate—systemic scleroderma	0.000274	0.000753	CcSEcCtD
Torasemide—Nausea—Prednisone—systemic scleroderma	0.000271	0.000746	CcSEcCtD
Torasemide—Diarrhoea—Methotrexate—systemic scleroderma	0.000261	0.000718	CcSEcCtD
Torasemide—Dizziness—Methotrexate—systemic scleroderma	0.000252	0.000694	CcSEcCtD
Torasemide—Vomiting—Methotrexate—systemic scleroderma	0.000242	0.000667	CcSEcCtD
Torasemide—Rash—Methotrexate—systemic scleroderma	0.00024	0.000662	CcSEcCtD
Torasemide—Dermatitis—Methotrexate—systemic scleroderma	0.00024	0.000661	CcSEcCtD
Torasemide—Headache—Methotrexate—systemic scleroderma	0.000239	0.000657	CcSEcCtD
Torasemide—Nausea—Methotrexate—systemic scleroderma	0.000226	0.000623	CcSEcCtD
